← Open Payments lookup

XITONG WU: Open Payments

NPI 1609491984 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,378 in 76 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $70 · 2025 $1,378

Food & beverage: $1,359Education: $19
CompanyPaymentsAmount
ABBVIE INC.29$423
Otsuka America Pharmaceutical, Inc.11$232
Teva Pharmaceuticals USA, Inc.10$152
Neurocrine BioSciences, Inc.5$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$86
E.R. Squibb & Sons, L.L.C.3$78
Axsome Therapeutics, Inc.3$66
Vanda Pharmaceuticals Inc.4$64
Janssen Pharmaceuticals, Inc2$57
Tris Pharma Inc2$33

Products named: VRAYLAR, INGREZZA, REXULTI, CAPLYTA, COBENFY, AUSTEDO XR, UZEDY, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.